High Court Won't Hear Apotex Appeal Over Prilosec
The high court on Monday denied the generic-drug maker's petition for writ of certiorari, letting stand a May 2007 federal district court ruling that Apotex infringed AstraZeneca's patents for the drugs.
The case will now be returned to the lower court to determine damages, AstraZeneca spokesman Blair Hains said.
“Obviously, we're pleased that the Supreme Court is not hearing...
To view the full article, register now.